Advertisement
Home »

Sotatercept Improves Exercise Capacity in Patients With PAH

Mar 22, 2023

REFERENCES & ADDITIONAL READING

  1. Hoeper MM, et al. The STELLAR Phase III Trial: A Study Of Sotatercept In Combination With Background Therapy For The Treatment Of Pulmonary Arterial Hypertension. Session 410-14, ACC Scientific Session 2023, 4–6 March, New Orleans, USA.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement